secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2026-08-06T20:11:21+00:00
Accession:  0001628280-26-054309
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SkinHealth Systems Q2 net loss $2.7M; revenue $72.1M (-8% YoY); delivery systems sold 770 (-20%)
--------------------------------------------------------------------------------

- Net loss of $2.7M vs net income of $19.7M in Q2 2025; net loss margin (3.7%).
- Total net sales $72.1M, down 8% from $78.2M; consumables $53.9M, delivery systems $18.3M.
- Delivery systems sold 770, down from 957; active install base 36,516, up 4% from 35,193.
- Adjusted EBITDA $17.0M, up 22% from $13.9M; adjusted EBITDA margin 23.6% vs 17.8%.
- Gross margin improved to 68.4% from 62.8%; adjusted gross margin 71.8% from 65.9%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026054309/0001628280-26-054309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828026054309/skin-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-054309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer